$5.6M
$682K
Subscribe Free
Read the full deal writeup
Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.
Get Free AccessFull Editorial Writeup
Profitable, well established independent pharmacy in Connecticut. Annual sales of over $5.6 Million and filling approximately 35,000 prescriptions per year with an estimated inventory of $400,000. Owner is looking to retire. Net discretionary income in 2025 after fully staffed was $682,000.
Why we like it
- Earnings Quality: $682K in discretionary income on $5.6M sales delivers a healthy 12.2% margin while operating fully staffed, indicating the business generates strong cash flow without requiring owner subsidization of labor costs. The prescription-based revenue model creates high visibility and recurring income streams since patients typically refill medications monthly.
- Durability & Moat: Independent pharmacies benefit from significant switching costs as patients rarely change pharmacies due to insurance networks, prescription histories, and relationship-based service. The business serves an essential healthcare function that customers cannot defer or substitute, creating defensive characteristics even during economic downturns.
- Market Tailwinds: An aging population drives increasing prescription volumes while regulatory barriers to entry (licensing, DEA registration, insurance credentialing) protect existing operators from new competition. Healthcare spending continues to grow as a percentage of GDP, providing secular tailwinds for prescription drug sales.
- Operator Advantage: The retiring owner creates an opportunity for a new operator to implement modern pharmacy management systems, expand clinical services like immunizations and health screenings, and potentially negotiate better reimbursement rates with insurance providers through improved operational efficiency.
How to improve it
- Clinical Services Expansion: Implement vaccination programs, medication therapy management, and basic health screenings to capture higher-margin clinical revenue streams while differentiating from chain competitors. These services typically command better reimbursement rates and strengthen patient relationships.
- Technology Upgrade: Install modern pharmacy management software with automated dispensing systems and patient communication tools to reduce labor costs and improve accuracy. Digital prescription management and automated refill reminders can increase script volume and reduce manual processing time.
- Insurance Network Optimization: Audit current insurance contracts and negotiate improved reimbursement rates, particularly for generic medications where margins are typically higher. Consider joining pharmacy buying groups to improve wholesale purchasing power and reduce cost of goods sold.
- Inventory Management: Implement just-in-time inventory systems and generic substitution protocols to reduce the $400K inventory carrying cost while maintaining service levels. Better inventory turnover can free up significant working capital for other growth initiatives.
- Compounding Services: Add sterile and non-sterile compounding capabilities to serve specialty medication needs in the local market, which typically command premium pricing and create additional barriers to patient switching to chain competitors.
Diligence notes
- Insurance Mix Analysis: Review the percentage of revenue from Medicare, Medicaid, and private insurance to understand reimbursement risk and potential regulatory exposure. High Medicaid concentration could indicate reimbursement pressure while strong private pay mix suggests better margins.
- Prescription Trend Verification: Validate the 35,000 annual script count through PBM reports and analyze prescription trends over the past 3-5 years to identify any declining patient base or shifts in medication types that could impact future revenue.
- Regulatory Compliance Audit: Confirm DEA license status, state pharmacy license, and controlled substance handling procedures are current and compliant. Review any past regulatory issues or inspections that could create future liability or operational disruption.
- Customer Concentration Risk: Analyze patient demographics and insurance mix to identify any concentration risk from major employers or healthcare systems that could shift business to chain competitors or mail-order pharmacies through formulary changes.